Gluskin Sheff & Assoc Inc Novo Nordisk A S Transaction History

Gluskin Sheff & Assoc Inc

  • $814 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$122.71 - $146.91 $122,710 - $146,910
1,000 Added 3.73%
27,790 $3.97 Million
Q4 2023

Feb 14, 2024
SELL
$87.78 - $105.45 $818,109 - $982,794
-9,320 Reduced 25.81%
26,790 $2.77 Million
Q3 2023

Nov 14, 2023
BUY
$90.94 - $199.54 $3.28 Million - $7.21 Million
36,110 New
36,110 $3.28 Million

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $233B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Gluskin Sheff & Assoc Inc Portfolio

Follow Gluskin Sheff & Assoc Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

News

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email